Markets

SPY734.07▲ +0.15%QQQ656.47▲ +1.46%DIA509.39▼ -0.95%GLD375.49▲ +0.81%TLT81.62▼ -0.38%BABA108.07▲ +2.64%NIO3.25▲ +1.56%PDD83.95▲ +2.19%Realtime derived data

$JAZZ

Independent coverage

227.32▼ −3.13%realtime derived

Independent research

Latest Research

Latest · 2026-11-06

Independent Researchsingle-name-earnings Earnings Results Data Desk2026-11-06

Jazz Pharmaceuticals quarterly revenue rises 10.4% to $1.24 billion

Jazz Pharmaceuticals' revenue growth is slowing. Results for the quarter ended September 30, 2026, from the earnings release filed with the SEC on Nov 2, 2026.

$JAZZ Octans Research

Coverage Timeline

2026-11-06

2026-11-06Jazz Pharmaceuticals quarterly revenue rises 10.4% to $1.24 billion

Jazz Pharmaceuticals quarterly revenue rises 10.4% to $1.24 billion→

Jazz Pharmaceuticals quarterly revenue rises 10.4% to $1.24 billion